Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Worldwide Autoimmune Partnering Deals Review 2014-2020: Gain Access Autoimmune Deal Headline, Upfront, Milestone and Royalty Data


DUBLIN, April 9, 2020 /PRNewswire/ -- The "Global Autoimmune Partnering 2014-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Global Autoimmune Partnering 2014 to 2020 provides the full collection of Autoimmune disease deals signed between the world's pharmaceutical and biotechnology companies since 2014.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Autoimmune disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Autoimmune deals.

The report includes coverage of the following autoimmune diseases: Multiple sclerosis, Restless leg syndrome, Dermatitis, Eczema, Alopecia, Psoriasis, Celiac disease, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis, Glomerulonephritis, Endometriosis, Immune thrombocytopenic purpura, Neutropenia, Graft versus host disease, Scleroderma, Systemic lupus erythematosus, Addison's disease, Diabetes Type 1, Ankylosing spondylitis, Juvenile arthritis, Psoriatic arthritis, Rheumatoid arthritis, Uveitis, Narcolepsy, Cronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Sarcoidosis, Meniere's disease, and other autoimmune disorders.

The report presents financial deal terms values for Autoimmune deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Autoimmune dealmaking trends.

In addition, a comprehensive appendix is provided with each report of all Autoimmune partnering deals signed and announced since 2014. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Autoimmune partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Autoimmune technologies and products.

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/hs32ds

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



SOURCE Research and Markets


These press releases may also interest you

at 12:25
Compassion & Choices today announced a historic collaboration with the Ventanillas de Salud (Windows of Health) network to launch a bilingual educational campaign during the COVID-19 crisis to inform U.S.-based Mexican immigrants about their full...

at 12:17
We know Canadians living with disabilities are facing significant challenges during this difficult time, with some experiencing job insecurity and others seeing increased costs for personal support workers, medication, and medical supplies. As we...

at 12:15
Living Care Lifestyles residents receive free laptops during the lockdown Caring for the community has always been a top priority for Net-Tech, Seattle's only Professional Technology Organization (PTO). When the pandemic lockdown separated area...

at 12:09
It's a Secret Med Spa, announces its 10th location opening in Scottsdale, located at the Kierland Commons 7012 E. Greenway Pkwy, Suite 140 Scottsdale, AZ 85254, Monday, June 8, 2020. This 2000 sq ft location has six treatment rooms and boasts state...

at 12:05
Innovative software developed by a team of local doctors and software developers helps families access "virtual" video visits with pediatricians. The software, called Cortico, uses video technology to connect patients to pediatric specialists at a...

at 12:02
The PA Clinical Network and Capital BlueCross announced an agreement to expand the availability of value-based care for Capital BlueCross members in Pennsylvania. The agreement provides resources from both organizations to support the delivery of...



News published on 9 april 2020 at 07:45 and distributed by: